Results 71 to 80 of about 20,680 (257)
Inverse pityriasis rosea secondary to COVID-19 vaccination
Proceedings, 2022 A 56-year-old woman presented for evaluation of a pruritic rash with associated body aches, fever, and chills that first appeared about 1 week after Johnson and Johnson COVID-19 vaccination.
Blayne Fenner +3 more
semanticscholar +1 more source
Az atópiás dermatitis diagnosztikája és differenciál diagnosztikája [PDF]
, 2018 L
Gáspár, Krisztián, Szegedi, Andrea
core +1 more source
An Atypical Case of Pityriasis Rosea Gigantea after Influenza Vaccination
Case Reports in Dermatology, 2014 Pityriasis rosea is a common erythematosquamous eruption, typically presenting along the cleavage lines of the skin. A wide spectrum of atypical manifestations may challenge even the most experienced physician.
Dimitrios Papakostas +5 more
doaj +1 more source
Interventions for pityriasis rosea
Cochrane Database of Systematic Reviews, 2019 Pityriasis rosea is a scaly, itchy rash that mainly affects young adults and lasts for 2 to 12 weeks. The effects of many available treatments are uncertain. This is an update of a Cochrane Review first published in 2007.To assess the effects of interventions for the management of pityriasis rosea in any individual diagnosed by a medical practitioner ...
Contreras‐Ruiz, Jose +5 more
openaire +4 more sources
Recurrent pityriasis rosea: A case report
Human Vaccines & Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
doaj +1 more source
Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19
Journal of Medical Virology, 2020 Cutaneous manifestations during Coronavirus Disease 2019 (COVID-19) include pityriasis rosea (PR) and PR-like eruptions1-3 . We describe a patient with PR demonstrating that concurrent viral reactivations may occur during COVID-19.
F. Drago +3 more
semanticscholar +1 more source
Molecular study of recent virus and its relationship to Pityriasis rosea.
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022 BACKGROUND A new type of coronavirus family severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been detected in individuals with several clinical symptoms named COVID-19, was recognized as a pandemic on March 11, 2020.
Ahmed Abdulhussein Kawen
semanticscholar +1 more source
Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies
Journal of the European Academy of Dermatology and Venereology, EarlyView.There is a concerning trend of widespread and severe superficial fungal infections caused by a new pathogen—Trichophyton indotineae—resistant to standard antifungal therapies. T. indotineae is now spreading globally and evolving. There is increasing urgency for healthcare providers and policy makers to initiate surveillance systems and antifungal ...
Aditya K. Gupta +11 more
wiley +1 more source
Pityriasis Rosea in a Female Runner [PDF]
, 2023 CASE HISTORY: The patient was a 40-year-old, physically active, mother and teacher. She had no previous history of autoimmune disease, Shingles, or other skin disorder. She reported having Herpes Zoster (Chicken Pox) at about six years old. In this case,
Long, Melissa D.
core +1 more source
A Typical Dermoscopic Pattern of PLEVA
Clinical Case Reports, Volume 13, Issue 8, August 2025.ABSTRACT PLEVA is a benign inflammatory disorder. Dermoscopy is a non‐invasive diagnostic modality. Thus, the new dermoscopic pattern mentioned in our literature can aid in the diagnosis of the disease, unlike the skin biopsy, which is an invasive modality and shows non‐specific features in PLEVA.
Mahesh Mathur +5 more
wiley +1 more source